Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

340B Entities Will Continue Fighting For Inpatient Drug Discounts

This article was originally published in The Pink Sheet Daily

Executive Summary

Issue is a top priority for Safety Net Hospitals for Pharmaceutical Access; provision to extend discounts to inpatient drugs was deleted from final health care reform bill.

You may also be interested in...



Bill Fixes 340B Discounts For Orphan Drugs In Children's Hospitals; Will More Entities Follow?

"Doc fix" bill to delay Medicare cuts in physician pay also says children's hospitals can get 340B discounts on orphan drugs - but some manufacturers are already dropping those discounts.

Bill Fixes 340B Discounts For Orphan Drugs In Children's Hospitals; Will More Entities Follow?

"Doc fix" bill to delay Medicare cuts in physician pay also says children's hospitals can get 340B discounts on orphan drugs - but some manufacturers are already dropping those discounts.

Inpatient Drug Discounts For 340B Providers Resurface In Jobs Bill

Dropped from health reform, a proposal to extend 340B discounts to inpatient drugs is included in "The American Jobs and Closing Tax Loopholes Act," sponsored by Senate and House committee chairmen.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel